MARATTO

article · Neuropharmacology

Targeting the AMPK/SIRT1-NLRP3 inflammasome axis: Simvastatin, Ezetimibe, and their combination attenuate 3-nitropropionic acid-induced striatal neurodegeneration in rats

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Sirtuins and Resveratrol in Medicine
  • Peroxisome Proliferator-Activated Receptors
  • Parkinson's Disease Mechanisms and Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.neuropharm.2026.111179

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.